Objectives To determine the epidemiology of healthcare harm observable in general practice records.
Design Retrospective cohort records review study.
Setting 72 general practice clinics were randomly selected from all 988 New Zealand clinics stratified by rurality and size; 44 clinics consented to participate.
Participants 9076 patient records were randomly selected from participating clinics.
Intervention Eight general practitioners examined patient records (2011–2013) to identify harms, harm severity and preventability. Analyses were weighted to account for the stratified sampling design and generalise findings to all New Zealand patients.
Main outcome measures Healthcare harm, severity and preventability.
Results Reviewers identified 2972 harms affecting 1505 patients aged 0–102 years. Most patients (82.0%, weighted) experienced no harm. The estimated incidence of harm was 123 per 1000 patient-years. Most harms (2160; 72.7%, 72.4% weighted) were minor, 661 (22.2%, 22.8% weighted) were moderate, and 135 (4.5%, 4.4% weighted) severe. Eleven patients died, five following a preventable harm. Of the non-fatal harms, 2411 (81.6%, 79.4% weighted) were considered not preventable. Increasing age and number of consultations were associated with increased odds of harm. Compared with patients aged ≤49 years, patients aged 50–69 had an OR of 1.77 (95% CI 1.61 to 1.94), ≥70 years OR 3.23 (95% CI 2.37 to 4.41). Compared with patients with ≤3 consultations, patients with 4–12 consultations had an OR of 7.14 (95% CI 5.21 to 9.79); ≥13 consultations OR 30.06 (95% CI 21.70 to 41.63).
Conclusions Strategic balancing of healthcare risks and benefits may improve patient safety but will not necessarily eliminate harms, which often arise from standard care. Reducing harms considered ‘not preventable’ remains a laudable challenge.
- primary care
- quality in health care
- health & safety
Data availability statement
The ethical approval for this study precludes any sharing of raw data; reasonable requests for deidentified data will be considered.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Strengths and limitations of this study
Large, detailed, retrospective general practice records review.
Stratified design accounts for the heterogeneity of the New Zealand population.
Patient perspective prioritised in interpretation of harm.
Determination of harm subjective, although measures were taken to improve reviewer consistency.
Audited hospital records in the USA publicised early measures of errors and harm associated with patient care.1 Despite thousands of subsequent related publications over the past three decades, patients’ experiences of harm across health systems, including primary care, are still largely unknown.2 Existing studies of routinely recorded data from primary care settings around the world provide widely variable estimates of patient harm.3
Population-based research is needed to understand the full spectrum of healthcare harm. This will quantify the burden of harm relative to unharmed patients, identify patient risk factors for harm and ascertain circumstances that are high-risk for harm, enabling an appropriate focus on prevention. The records review method can provide research data about populations accessing healthcare. This method is feasible in primary care where records are electronic and patients’ contacts throughout the health system are recorded.4–7
In this study, we aimed to estimate the incidence, distribution, severity and preventability of patient harms in New Zealand, and to identify risk factors for harm from the whole-of-health-system perspective afforded by electronic health records in general practice clinics.
New Zealand is a country of 4.9 million people. General practices provide the bulk of primary healthcare and act as a gateway to hospital care and some allied health services. General practitioners and practice nurses comprise most of the workforce. Practices receive capitated government funding based on the demographic profile of their patients; patients also contribute a fee-for-service co-payment. Electronic health records have been used in New Zealand general practices for over three decades. They are a repository of comprehensive information about each patient’s interactions with the health system, including general practice clinic notes, investigations, prescriptions and summaries of other healthcare received (such as hospital discharge summaries and secondary care reviews).
The study design is a stratified, two-level cluster, retrospective cohort review of New Zealand general practice electronic health records.8 9 Patient records were randomly selected from consenting practices that were randomly selected after stratification by practice size and location. Three years of patient records were reviewed (2011–2013, inclusive).
Patient and public involvement
Patients or the public were not involved in the design, recruitment, conduct, reporting or dissemination of our research. Study clinics were advised of the analysis of data from their clinic, with comparison data presented from other similar clinics.
Ministry of Health data were used to identify all 988 general practice clinics that received capitation public funding for the first quarter of 2014, where a total of 4 289 001 people (95.4% of the 2014 national population) were registered as patients. Practices were classified as large, medium or small by enrolled patient numbers, divided into tertiles. Practices were also classified as rural or urban by address. Combinations of these practice size and practice location classifications formed six strata. Twelve practices from each stratum (72 practices) were randomly selected and invited to participate; 44 practices consented to participate. A review of the characteristics of the participating general practices found that they were relatively homogeneous, apart from size and location.9
Patient selection and electronic records
Based on our feasibility study, we estimated 1345 patients per strata were needed to identify 5% difference in harm rates between strata.8 To allow for some patients receiving no healthcare during the study period, we aimed to study 1500 patients per stratum (~9000 patients in total). Patients were randomly selected from participating practices at the mid-point of the 3-year study period, 1 July 2012. All patients enrolled on that date were eligible for selection, regardless of age, health status or any other characteristic.
The electronic health records of these patients for the study period were collated by the study’s bespoke electronic data extraction program. This software redacted names and addresses. Study reviewers only had access to extracted records following redaction. The records contained demographic data (age, sex, ethnicity and socioeconomic deprivation level), free-text consultation notes, laboratory and radiology requests and results, alerts and prescriptions. Electronically stored referrals, clinic letters and hospital discharge summaries were also extracted and reviewed whenever available.
Reviews were conducted by eight clinically active general practitioners with a minimum of 10 years’ experience. Reviewer training sessions were held at the commencement of the study. Feedback from double-reviewed files (948/9076, 10.4%) was used to further improve reviewer consistency. The range of agreement between pairs of reviewers was 66.7%–100.0%; overall kappa=0.344, p<0.001. Differences between reviewers were discussed, and consensus agreement was obtained to determine the final recorded outcome for the double-reviewed files.
Reviewers read the entire records and identified episodes where patients experienced harm. They assessed harm severity and preventability. Harms were recorded in descriptive form. Two investigators (SD, S Leitch) coded harms using the Medical Dictionary for Regulatory Activities (MedDRA) V.18.0 codes.10
Each record represented a unique patient. Age, sex, ethnicity and socioeconomic deprivation describe the demography of study patients. Number of general practice consultations, practice size and practice location were included as explanatory variables in the univariate and multivariable logistic regression models. Logistic regression explored gradients of harm across each variable by using ‘experienced at least one harm’ as the binary outcome. Univariate analysis was completed first (unadjusted), and multivariable analysis adjusted for possible confounding effects among all variables. Incidence rates were calculated as the number of events divided by the total number of person-years of follow-up (eg, 3*9076 years, 3 years per person). All analyses were completed in Stata statistical software V.15.1 using the ‘svy’ suite of commands with study-design-based sampling weights so that results are generalisable to the New Zealand population. Unweighted analyses have been provided for comparison. Cases with missing data were excluded only from the multivariable analysis. The authors had access to all of the statistical reports and tables.
Harm was defined as ‘physical, emotional or financial negative consequences to patients directly arising from healthcare, beyond the usual consequences of care, and not attributable to patients’ health conditions.’8 11 All patient files were reviewed by at least one of the eight clinician researchers, who identified harms from longitudinal patient records, and assessed their severity and preventability. Medical errors were not studied.10
Reviewers assessed harm severity by considering whether each harm led to additional general practice visits or treatments, emergency department visits or hospital admissions. Severity options were ‘minor’, ‘moderate’, ‘severe’ or ‘death.’8 Relatively trivial harms that were short-lived were coded minor (eg, thrush, nausea and patient inconvenience, such as being given the wrong prescription). Harms with increased or persistent morbidity were coded moderate (eg, fractures, unplanned pregnancy and poor diabetic control). Severe harms included events such as myocardial infarction, renal failure and morphine overdose.
Following McKay et al,12 reviewers used their clinical expertise to assess harm preventability from five options. After researcher discussion and consensus, these options were aggregated in analysis to ‘preventable or potentially preventable’ (original codes: ‘preventable and originated in primary care’ and ‘potentially preventable and originated in primary care’) and ‘not preventable’ (‘not preventable, standard treatment,’ ‘not preventable and originated in primary care,’ ‘not preventable and originated in secondary care’ and ‘preventable and originated in secondary care OR not preventable and originated in primary care’).
Although New Zealanders can identify with multiple ethnicities, prioritised ethnicity is used in the health sector and this study.13 Ethnicity is recorded by each practice at time of patient enrolment. Ethnicity data were missing for 144 out of 9076 patients (1.6%).
The New Zealand Deprivation Index (NZDep)14 is a national meshblock level index but used as a proxy for individual socioeconomic status. We used NZDep13 (based on the 2013 census) quintiles, where 1=least deprived and 5=most deprived.15 Our data abstraction process captured the NZDep relevant to each patient’s address without downloading the addresses themselves. NZDep was missing for 894 out of 9076 patients (9.9%).
Age and number of consultations were grouped for improved clinical relevance in terms of identifying patients at increased risk of harm. Age was sorted into three groups: 0–49 years, 50–69 years and 70+ years. Number of consultations with a general practitioner, practice nurse or nurse practitioner during the 3-year study period were sorted into three groups: low (0–3 consultations), moderate (4–12 consultations) and high healthcare users (13+ consultations).
Over the three study years, the 9076 study patients had 115 797 unique general practice visits, 212 963 prescriptions of 833 different pharmaceuticals and 2578 hospital admissions. Patients were aged <1 year (n=9) to >100 years (n=7), with a bimodal age distribution typical of general practice consulting populations. Reviewers identified 2972 harms experienced by 1505 patients. After applying weighting, the incidence rate of harm was 123 harms per 1000 patient-years, and the incidence rate of preventable or potentially preventable harm was 26 harms per 1000 patient-years. Figure 1 shows the weighted patient distribution of harmed and unharmed patients by age group, calculated as a percentage of total number of patients. Table 1 shows the demographic profile of the study sample, both unweighted and weighted for extrapolation to the New Zealand population.
Older age and having more general practice visits were associated with a significantly increased risk of harm (table 2 and online supplemental table 1). Compared with patients aged <50 years, older patients had increased odds of experiencing one or more healthcare harm; 50–69 years OR 1.77 (95% CI 1.61 to 1.94), >70 years OR 3.23 (95% CI 2.37 to 4.41). Increasing exposure to healthcare was associated with increased likelihood of experiencing harm. Compared with patients with ≤3 general practice consultations over the three study years, patients with more consultations had increased odds of experiencing one or more harms; 4–12 consultations OR 7.14 (95% CI 5.21 to 9.79), >13 consultations OR 30.06 (95% CI 21.70 to 41.63).
Among patients experiencing harm, 831 (55.2%, 54.5% weighted) had one harm, 329 (21.9%, 20.5% weighted) had two harms and 345 (22.9%, 25.0% weighted) patients had three or more harms. Median age increased with increasing number of harms. Patients with three or more harms experienced 3–15 harms (median 4; IQR 3–6).
The majority of harms were considered not preventable (2420/2972, 81.4%, 79.2% weighted). Most harms (2160; 72.7%, 72.4% weighted) were considered minor, but 661 (22.2%, 22.8% weighted) were of moderate severity, and 135 (4.5%, 4.4% weighted) severe (table 3). Forty-five patients were hospitalised; the estimated incidence of hospitalisation was 2.3 per 1000 patient-years. Eleven patients died as a result of harm: for five of those patients, their harms were considered potentially preventable. The estimated incidence of death was 0.5 per 1000-patient years. Of the patients who died, four had one harm, two patients had two harms, three patients had three harms and two had four harms. Table 3 shows the severity and preventability of harms, with examples in each category.
Most patients did not experience harm identifiable from their medical records; however, we estimate an incidence rate of 123 harms per 1000 patient-years. Despite most harm being considered minor, general practice records reveal the extent of severe harms, including preventable deaths. Older people experienced more harm, irrespective of their number of consultations. Having more medical encounters was also associated with increased risk of harm, regardless of age. Harm was not found to be associated with patient gender, ethnicity, socioeconomic deprivation or the size or location of the general practice.
Strengths and limitations
This paper describes data from a large, New Zealand-wide sample of patient records, providing insight into harm patients’ experienced in general practice and in other healthcare settings.4 The whole-of-healthcare lens afforded by this method follows patients’ healthcare journeys across settings, identifying in one setting delayed harm arising from care in another. The stratified design allowed heterogeneity of the population be accounted for in a probabilistic manner.
Medical records contain both healthcare providers’ observations and reports of patients’ experiences—but only if patients tell their healthcare provider and that experience is documented. Clinicians frequently disregard minor harms an acceptable consequence of care (eg, nausea with antibiotics), and ignore patient inconvenience and expense. However, we have privileged patients’ experiences, interpreting these recorded events as being serious enough to call ‘harm’ using a broad patient-focused definition.8 11 We acknowledge more patients experienced harm than was recorded. Not all reported harm would be recorded, and many patients face access barriers both to receive care and to report harm.16–18
The records review method has been criticised for lack of reliability and reproducibility19 20: we consider it is the best method we have available to obtain a general (if imperfect) assessment of patient harm across the health system. We attempted to address issues of reliability with reviewer training in the early phases of the study; our kappa value was calculated from the double-reviewed files used for training.
Comparison with literature
No directly comparable studies have been published. Our focus on all harms is unique—similar studies typically focus on preventable harms such as medical error or patient safety incidents.5 21 22 Our method is comprehensive—other studies examine records only from patients considered at high-risk of experiencing harm, thus missing harms experienced by low-risk patients.21–23 Published studies to date provide vastly different measures and rates of harm, likely attributable to differences in definitions and methods.3 4
We estimate an incidence rate of 123 harms per 1000 patient-years, with approximately 20% of those harms considered preventable or potentially preventable. These rates are substantially higher than other general practice record review studies. Gaal et al5 identified 58 per 1000 patients affected by patient safety incidents over 1 year in the Netherlands, Tsang et al24 examined general practice Read codes to find surgical and medical injury in 0.72 per 1000 consultations and adverse drug reactions in 1.26 per 1000 consultations annually in England, Madden et al23 found harms in 19.1% of patient records selected by a trigger tool in Northern Ireland and the Republic of Ireland, while in England Avery et al22 found a rate of avoidable significant harm was 35.6 per 100000 patient-years after examining the records of high-risk patients. We posit our rates of harm are higher than all these studies because of our broad definition of harm, our examination of all patient records (not just records of patients considered high risk or identified by a trigger tool), and the comprehensive content of the electronic health records we reviewed.
Our other major findings are consistent with extant literature. The majority of harms observed were of minor severity and were considered not preventable. This is consistent with other studies of patient safety in primary care.5 22 25 Older patients and patients having more consultations were at increased risk of harm in our study. This is understandable; people who have more clinical encounters have more potential for harm, and increasing multimorbidity and polypharmacy with age and over time is a well-recognised phenomenon.26–28 We also found practice size and location were not associated with increased risk of harm, which may be explained by the fact our study practices were relatively homogenous.9 Previous studies have shown that practice size and location may affect patient care, but the literature is inconsistent, suggesting perhaps continuity of care is more important than practice size or location.29–31
Our research indicates that ‘first, do no harm’ is out of step with patients’ experience of healthcare. We found that patient harm is common and mostly non-preventable, as it arose from routine care; recognising this should inform shared decision-making when considering investigation and treatment options. However, to accept these harms as inevitable is defeatist, diminishing impetus for change.32
The challenge is to reduce the burden of patient harm.32 Clinicians need technologies to reduce cognitive load, such as automatic identification of patients at high risk of patient harm, and prescribing and deprescribing support. General practices work relatively autonomously; sector-wide coordination could develop policies, training and patient safety cultural practices that could contribute to safer work systems. Finally, patients should be involved in developing standard measures for patient harm in general practice. This will help focus patient safety measures as well as improve the quality of future research in this area.
This analysis of real-world general practice data increases our understanding of patient harm. Patient harm is common, but was mostly considered minor and non-preventable. Strategic balancing of healthcare risks and benefits may improve patient safety but will not necessarily eliminate harms, which often arise from standard care. Reducing patient harm arising from routine care is a difficult but laudable challenge.
Data availability statement
The ethical approval for this study precludes any sharing of raw data; reasonable requests for deidentified data will be considered.
This study was reviewed by the Minister of Health, the Royal New Zealand College of General Practitioners and the Ngāi Tahu Research Consultation Committee. Ethical approval for this study was obtained from the University of Otago Human Ethics Committee (HD14/32). Consideration of ethical issues pertaining to this study design has been published.33
Thanks to all the general practices who participated in this work and to Jason Hall from Best Practice Advocacy Centre New Zealand (bpacNZ) Clinical Solutions, who provided IT support for this work.
Contributors S Leitch was a clinical coordinator for the study, recruited the study practices, reviewed general practice records, coded harms, conducted statistical analyses and wrote this manuscript. SL is the guarantor for this research and as corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. SD is the Principal Investigator, conceived and undertook the SHARP study design, obtained research funding, coded harms and critically reviewed this manuscript. WC reviewed general practice records, coded harms and critically reviewed this manuscript. DR, KW, KE, AM, MW, S Lillis and MT reviewed general practice records and critically reviewed this manuscript. AS contributed to the study design and critically reviewed this manuscript.
Funding This study was funded by the Health Research Council of New Zealand (HRC-14-185).
Competing interests All authors had financial support from the Health Research Council New Zealand for the submitted work; MT is the CEO of bpacNZ, the company subcontracted to develop the bespoke data extraction software, extract the data, manage the file allocation to reviewers and collate the results for the researchers. DR has received payment from Therapeutic Goods Administration—payment for consultancy services, and Medsafe and New Zealand Formulary—payment for committee and board membership. No other authors have any competing interests to declare; there are no other relationships or activities that could appear to have influenced the submitted work.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.